Related references
Note: Only part of the references are listed.Cerebrospinal fluid soluble TREM2 is higher in Alzheimer disease and associated with mutation status
Laura Piccio et al.
ACTA NEUROPATHOLOGICA (2016)
TREM2 deficiency reduces the efficacy of immunotherapeutic amyloid clearance
Xianyuan Xiang et al.
EMBO MOLECULAR MEDICINE (2016)
sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early-stage Alzheimer's disease and associate with neuronal injury markers
Marc Suarez-Calvet et al.
EMBO MOLECULAR MEDICINE (2016)
In Vivo Imaging of Microglial Activation by Positron Emission Tomography with [11C] PBR28 in the 5XFAD Model of Alzheimer's Disease
Nazanin Mirzaei et al.
GLIA (2016)
TREM2-mediated early microglial response limits diffusion and toxicity of amyloid plaques
Yaming Wang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2016)
Glial Activation and Glucose Metabolism in a Transgenic Amyloid Mouse Model: A Triple-Tracer PET Study
Matthias Brendel et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
Increased cerebrospinal fluid soluble TREM2 concentration in Alzheimer's disease
Amanda Heslegrave et al.
MOLECULAR NEURODEGENERATION (2016)
Early changes in CSF sTREM2 in dominantly inherited Alzheimer's disease occur after amyloid deposition and neuronal injury
Marc Suarez-Calvet et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Automated Spatial Brain Normalization and Hindbrain White Matter Reference Tissue Give Improved [18F]-Florbetaben PET Quantitation in Alzheimer's Model Mice
Felix Overhoff et al.
FRONTIERS IN NEUROSCIENCE (2016)
TREM2 Lipid Sensing Sustains the Microglial Response in an Alzheimer's Disease Model
Yaming Wang et al.
CELL (2015)
Astrocytosis precedes amyloid plaque deposition in Alzheimer APPswe transgenic mouse brain: a correlative positron emission tomography and in vitro imaging study
Elena Rodriguez-Vieitez et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2015)
Soluble amyloid triggers a myeloid differentiation factor 88 and interferon regulatory factor 7 dependent neuronal type-1 interferon response in vitro
Myles Robert Minter et al.
JOURNAL OF NEUROINFLAMMATION (2015)
In Vivo Detection of Age- and Disease-Related Increases in Neuroinflammation by 18F-GE180 TSPO MicroPET Imaging in Wild-Type and Alzheimer's Transgenic Mice
Bin Liu et al.
JOURNAL OF NEUROSCIENCE (2015)
Neuroinflammation in Alzheimer's disease
Michael T. Heneka et al.
LANCET NEUROLOGY (2015)
Amyloid-PET predicts inhibition of de novo plaque formation upon chronic γ-secretase modulator treatment
M. Brendel et al.
MOLECULAR PSYCHIATRY (2015)
Improved longitudinal [18F]-AV45 amyloid PET by white matter reference and VOI-based partial volume effect correction
Matthias Brendel et al.
NEUROIMAGE (2015)
TREM2 and Risk of Alzheimer's Disease - Friend or Foe?
Elizabeth G. Phimister
NEW ENGLAND JOURNAL OF MEDICINE (2015)
A Genome-wide Gene-Expression Analysis and Database in Transgenic Mice during Development of Amyloid or Tau Pathology
Mar Matarin et al.
CELL REPORTS (2015)
Cross-Sectional Comparison of Small Animal [F-18]-Florbetaben Amyloid-PET between Transgenic AD Mouse Models
Matthias Brendel et al.
PLOS ONE (2015)
The development of an automated and GMP compliant FASTlab™ Synthesis of [18F]GE-180; a radiotracer for imaging translocator protein (TSPO)
Torild Wickstrom et al.
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS (2014)
Modulation of inflammation in transgenic models of Alzheimer's disease
Amy M. Birch et al.
JOURNAL OF NEUROINFLAMMATION (2014)
Detection of Microglial Activation in an Acute Model of Neuroinflammation Using PET and Radiotracers 11C-(R)-PK11195 and 18F-GE-180
Alex M. Dickens et al.
JOURNAL OF NUCLEAR MEDICINE (2014)
TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis
Gernot Kleinberger et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
MicroPET imaging and transgenic models: a blueprint for Alzheimer's disease clinical research
Eduardo R. Zimmer et al.
TRENDS IN NEUROSCIENCES (2014)
Sequential Proteolytic Processing of the Triggering Receptor Expressed on Myeloid Cells-2 (TREM2) Protein by Ectodomain Shedding and γ-Secretase-dependent Intramembranous Cleavage
Patrick Wunderlich et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Longitudinal Assessment of Cerebral β-Amyloid Deposition in Mice Overexpressing Swedish Mutant β-Amyloid Precursor Protein Using 18F-Florbetaben PET
Axel Rominger et al.
JOURNAL OF NUCLEAR MEDICINE (2013)
Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study
Victor L. Villemagne et al.
LANCET NEUROLOGY (2013)
Variant of TREM2 Associated with the Risk of Alzheimer's Disease
Thorlakur Jonsson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
TREM2 Variants in Alzheimer's Disease
Rita Guerreiro et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Regional Expansion of Hypometabolism in Alzheimer's Disease Follows Amyloid Deposition with Temporal Delay
Stefan Foerster et al.
BIOLOGICAL PSYCHIATRY (2012)
Mouse models of Alzheimer's disease
Alicia M. Hall et al.
BRAIN RESEARCH BULLETIN (2012)
Applications of positron emission tomography in animal models of neurological and neuropsychiatric disorders
Kanwar Virdee et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2012)
Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
Randall J. Bateman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Small-Animal PET Imaging of Amyloid-Beta Plaques with [11C]PiB and Its Multi-Modal Validation in an APP/PS1 Mouse Model of Alzheimer's Disease
Andre Manook et al.
PLOS ONE (2012)
The Alzheimer’s Disease Neuroimaging Initiative: A review of papers published since its inception
Michael W. Weiner et al.
Alzheimers & Dementia (2011)
Development of Alzheimer-disease neuroimaging-biomarkers using mouse models with amyloid-precursor protein-transgene expression
Stefan J. Teipel et al.
PROGRESS IN NEUROBIOLOGY (2011)
Validation of the Octamouse for Simultaneous 18F-Fallypride Small-Animal PET Recordings from 8 Mice
Axel Rominger et al.
JOURNAL OF NUCLEAR MEDICINE (2010)
Classification and basic pathology of Alzheimer disease
Charles Duyckaerts et al.
ACTA NEUROPATHOLOGICA (2009)
Voxel-based morphometry in the R6/2 transgenic mouse reveals differences between genotypes not seen with manual 2D morphometry
S. J. Sawiak et al.
NEUROBIOLOGY OF DISEASE (2009)
Expression of Transgenic APP mRNA Is the Key Determinant for Beta-Amyloid Deposition in PS2APP Transgenic Mice
Laurence Ozmen et al.
NEURODEGENERATIVE DISEASES (2009)
Worldwide variation in the doubling time of Alzheimer's disease incidence rates
Kathryn Ziegler-Graham et al.
ALZHEIMERS & DEMENTIA (2008)
TREM2 is upregulated in amyloid plaque-associated microglia in aged APP23 transgenic mice
Stefanie Frank et al.
GLIA (2008)
Three-dimensional cerebral vasculature of the CBA mouse brain: A magnetic resonance imaging and micro computed tomography study
A. Dorr et al.
NEUROIMAGE (2007)
Kinetic modeling of amyloid binding in humans using PET imaging and Pittsburgh Compound-B
JC Price et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2005)
Share Paper
